AbbVie @abbvie · 27 Aug 2026
JUST IN: Learn about our submission to the @EMA_News for subcutaneous induction of one of our medicines in adults with moderately to severely active #CrohnsDisease: https://t.co/n22gi2cLPB https://t.co/CmbncEnHvH
1 707Views
6Likes
0Reposts
1Replies
0Quotes
0Bookmarks
Is that a lot?
1.86×vs this author's median917 views is typical
75Percentile for this authorof 8 recent posts
0.66×vs 10K–100K median2 578 views is typical
2.15%Reachviews ÷ followers
0.41%Engagement rateof viewers reacted